Publications by authors named "Johnathan Lancaster"

Claim this Profile
P
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
Sharon E Robertson, Maya Yasukawa, Douglas C Marchion, Yin Xiong, Syeda Mahrukh Hussnain Naqvi, Johnathan M Lancaster

PLoS One· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
David Stein, Ernesto Oviedo-Orta, Wendy A Kampman, Jennifer McGinniss, George Betts, Johnathan M Lancaster

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Elisha Hughes, Placede Tshiaba, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Johnathan M Lancaster

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
Daryoush Saeed-Vafa, Douglas C Marchion, Susan M McCarthy, Ardeshir Hakam, Alexis Lopez, Johnathan M Lancaster

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated () Gene are Associated with High and Moderate Risks for Multiple Cancers.
Michael J Hall, Ryan Bernhisel, Elisha Hughes, Katie Larson, Eric T Rosenthal, Johnathan M Lancaster

Cancer Prev Res (Phila)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.
Shelly Cummings, Susana San Roman, Jennifer Saam, Ryan Bernhisel, Krystal Brown, Johnathan M Lancaster

J Ovarian Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster

J Comp Eff Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Gregory S Calip, John Kidd, Ryan Bernhisel, Hannah C Cox, Jennifer Saam, Johnathan M Lancaster

Breast Cancer Res Treat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.
Shannon Gallagher, Elisha Hughes, Susanne Wagner, Placede Tshiaba, Eric Rosenthal, Johnathan Lancaster

JAMA Netw Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.
Elisha Hughes, Placede Tshiaba, Shannon Gallagher, Susanne Wagner, Thaddeus Judkins, Johnathan Lancaster

JCO Precis Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Hatem Soliman, Susanne Wagner, Darl D Flake, Mark Robson, Lee Schwartzberg, Johnathan M Lancaster

Ann Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor.
Malek B Hannouf, Dale Muzzey, Ralf Kronenwett, Johnathan M Lancaster

J Comp Eff Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Bernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, Yin Xiong, Atif Siddique, Johnathan M Lancaster

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay.
Hatem Soliman, Darl D Flake, Anthony Magliocco, Mark Robson, Lee Schwartzberg, Johnathan Lancaster

JCO Precis Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Distant Recurrence Using EndoPredict Among Women with ER, HER2 Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Martin Filipits, Peter Dubsky, Margaretha Rudas, Richard Greil, Marija Balic, Johnathan M Lancaster

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Gregory E Idos, Allison W Kurian, Charité Ricker, Duveen Sturgeon, Julie O Culver, Johnathan M Lancaster

JCO Precis Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
Bernadette M Boac, Yin Xiong, Sachin M Apte, Robert M Wenham, Mian M Shahzad, Johnathan M Lancaster

Am J Obstet Gynecol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a genetic counseling requirement prior to genetic testing.
David D Stenehjem, Trang Au, Amy M Sainski, Hillevi Bauer, Krystal Brown, Johnathan Lancaster

BMC Health Serv Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Johnathan Lancaster

Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.
Patricia L Judson, Reem Abdallah, Yin Xiong, Judith Ebbert, Johnathan M Lancaster

Integr Cancer Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Payer Constraints on Access to Genetic Testing.
Pat Whitworth, Peter Beitsch, Christopher Arnell, Hannah C Cox, Krystal Brown, Johnathan M Lancaster

J Oncol Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health.
Gina Shetty, Julian A Sanchez, Johnathan M Lancaster, Lauren E Wilson, Gwendolyn P Quinn

Patient Educ Couns· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
Cheng-Xiong Xu, Meng Xu, Lei Tan, Hua Yang, Jennifer Permuth-Wey, Johnathan M Lancaster

J Biol Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.
Stephen H Bush, Sharon Tollin, Douglas C Marchion, Yin Xiong, Forough Abbasi, Johnathan M Lancaster

Mol Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.
Nadim Bou Zgheib, Douglas C Marchion, Stephen H Bush, Patricia L Judson, Robert M Wenham, Johnathan M Lancaster

Oncol Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis